BOONE, N.C., Oct. 26, 2018 /PRNewswire/ -- Pneuma Respiratory, Inc., which has developed PNEUMAHALER™, the first breath-activateddigital inhaler (BDI), announced its Board of Directors has elected shareholder J. Knox Singleton to the Board. Until his retirement in July 2018, Mr. Singleton, served for 35 years as the CEO of Inova Health System, the
"We are honored to have Knox join our Board," stated Pneuma Chief Executive Officer and Co-founder Eric Hunter. "His extensive experience having built a successful and innovative healthcare business is a tremendous asset. We look forward to working with Knox as we continue to grow our organization."
"When I initially invested in the Company, I was struck by the level of technical expertise, energy and passion displayed by Eric and the rest of the team. I am very excited about joining the Pneuma Respiratory Board to assist the company with its efforts to deploy its technology to improve outcomes for patients suffering from asthma and COPD," said Mr. Singleton.
About Pneuma Respiratory
Launched in 2015, Pneuma Respiratory is a pharmaceutical company based in Boone, North Carolina. With a global team of researchers, physicians, designers and engineers, Pneuma has created PNEUMAHALER™, the first fully integrated digital breath activated inhaler. The inhaled delivery system has integrated Bluetooth technology to provide feedback on drug delivery to patients, family members and health care providers. Using Pneuma's digital droplet ejector technology, Pneuma's device, although currently available for investigational purposes only, has the potential to ultimately deliver a spectrum of novel therapies, including biologics, to the lungs. For more information visit www.pneumarespiratory.com
Media contact: Kade McNaughton email@example.com 828-434-6433
View original content:http://www.prnewswire.com/news-releases/pneuma-respiratory-inc-announces-j-knox-singleton-joins-the-board-of-directors-300738650.html
SOURCE Pneuma Respiratory
Subscribe to our Free Newsletters!